{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:29:10Z","timestamp":1781162950659,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2261-12-5","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T13:14:05Z","timestamp":1329225245000},"source":"Crossref","is-referenced-by-count":26,"title":["Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan"],"prefix":"10.1186","volume":"12","author":[{"given":"Joaquin","family":"De Haro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Acin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"issue":"5 Suppl 4","key":"422_CR1","first-page":"3","volume":"82","author":"J Olin","year":"1990","unstructured":"Olin J, Young J, Graor R, Ruschhaupt W, Bartholomew J: The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990, 82 (5 Suppl 4): 3-8.","journal-title":"Circulation"},{"key":"422_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/000331979304400704","volume":"44","author":"Y Yorukoglu","year":"1993","unstructured":"Yorukoglu Y, Ilgit E, Zengin M, Nazliel K, Salman E, Yucel E: Thromboangiitis obliterans (Buerger's disease in women-a reevaluation). Angiology. 1993, 44: 527-532. 10.1177\/000331979304400704.","journal-title":"Angiology"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0828-282X(09)70099-6","volume":"25","author":"T Yoshimuta","year":"2009","unstructured":"Yoshimuta T, Akutsu K, Okajima T, Tamori Y, Kubota Y, Takeshita S: Corkscrew collaterals in Buerger's disease. Can J Cardiol. 2009, 25: 365-10.1016\/S0828-282X(09)70099-6.","journal-title":"Can J Cardiol"},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/000331970605700110","volume":"57","author":"LT Cooper","year":"2006","unstructured":"Cooper LT, Henderson SS, Ballman KV, Offord KP, Tse TS, Holmes DR, Hurt RD: A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease). Angiology. 2006, 57: 73-78. 10.1177\/000331970605700110.","journal-title":"Angiology"},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"R254","DOI":"10.1152\/ajpregu.00584.2009","volume":"298","author":"SW Watts","year":"2010","unstructured":"Watts SW: Endothelin receptors: what's new and what do we need to know?. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R254-260. 10.1152\/ajpregu.00584.2009.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0755-4982(06)74645-0","volume":"35","author":"D Launay","year":"2006","unstructured":"Launay D, Diot E, Pasquier E, Mouthon L, Boullanger N, Fain O, Jego P, Carpentier P, Hatron PY, Hachulla E: Bosentan for treatment of active digital ulcers in patients with systemic sclerosis. Presse Med. 2006, 35: 587-592. 10.1016\/S0755-4982(06)74645-0.","journal-title":"Presse Med"},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00296-008-0789-z","volume":"29","author":"M Funauchi","year":"2009","unstructured":"Funauchi M, Kishimoto K, Shimazu H, Nagare Y, Hino S, Yano T, Kinoshita K: Effects of bosentan on the skin lesions: an observational study from a single center in Japan. Rheumatol Int. 2009, 29: 769-775. 10.1007\/s00296-008-0789-z.","journal-title":"Rheumatol Int"},{"key":"422_CR8","first-page":"135","volume":"59","author":"MT Riccardi","year":"2007","unstructured":"Riccardi MT, Chial\u00e0 A, lannone F, Grattagliano V, Covelli M, Lapadula G: Treatment of digital ulcers in systemic sclerosis with endothelin-1 receptor antagonist (bosentan). Reumatismo. 2007, 59: 135-139.","journal-title":"Reumatismo"},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3899\/jrheum.080992","volume":"36","author":"N Tsifetaki","year":"2009","unstructured":"Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA: Bosentan for Digital Ulcers in Patients with Systemic Sclerosis: A Prospective 3-year Follow up Study. J Rheumatol. 2009, 36: 1550-1551. 10.3899\/jrheum.080992.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"422_CR10","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1016\/S0167-5273(98)00175-2","volume":"66","author":"S Shionoya","year":"1998","unstructured":"Shionoya S: Diagnostic criteria of Buerger's disease. Int J Cardiol. 1998, 66 (Suppl 1): S243-5.","journal-title":"Int J Cardiol"},{"issue":"1","key":"422_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0749-0712(21)00953-7","volume":"9","author":"NB Zimmerman","year":"1993","unstructured":"Zimmerman NB: Occlusive vascular disorders of the upper extremity. Hand Clin. 1993, 9 (1): 139-50.","journal-title":"Hand Clin"},{"issue":"2","key":"422_CR12","first-page":"54","volume":"11","author":"K Ouriel","year":"1998","unstructured":"Ouriel K: Noninvasive diagnosis of upper extremity vascular disease. Semin Vasc Surg. 1998, 11 (2): 54-9.","journal-title":"Semin Vasc Surg"},{"issue":"1","key":"422_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/jssh.2001.21780","volume":"1","author":"D Ruch","year":"2001","unstructured":"Ruch D, Koman LA, Smith TL: Chronic vascular disorders of the upper extremity. J Am Society Surg Hand. 2001, 1 (1): 73-80. 10.1053\/jssh.2001.21780.","journal-title":"J Am Society Surg Hand"},{"issue":"6","key":"422_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0003319708327787","volume":"60","author":"FJ Maldonado","year":"2009","unstructured":"Maldonado FJ, Miralles J de H, Aguilar EM, Gonzalez AF, Garc\u00eda JR, Garc\u00eda FA: Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology. 2009, 60 (6): 725-731. 10.1177\/0003319708327787.","journal-title":"Angiology"},{"issue":"Suppl S","key":"422_CR15","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG: TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007, 45 (Suppl S): S5-67.","journal-title":"J Vasc Surg"},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jvs.2003.08.006","volume":"39","author":"T Ohta","year":"2004","unstructured":"Ohta T, Ishioashi H, Hosaka M, Sugimoto I: Clinical and social consequences of Buerger Disease. J Vasc Surg. 2004, 39: 176-180. 10.1016\/j.jvs.2003.08.006.","journal-title":"J Vasc Surg"},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/rheumatology\/kel388","volume":"46","author":"X Pu\u00e9chal","year":"2007","unstructured":"Pu\u00e9chal X, Fiessinger JN: Thromboangiitis obliterans or Buerger's disease:challenges for the rheumatologist. Rheumatology. 2007, 46: 192-199.","journal-title":"Rheumatology"},{"issue":"5","key":"422_CR18","doi-asserted-by":"publisher","first-page":"690.e1","DOI":"10.1016\/j.avsg.2010.03.011","volume":"24","author":"JA Todoli","year":"2010","unstructured":"Todoli JA, Hern\u00e1ndez MM, Arr\u00e9bola MA: Efficacy of bosentan in digital ischemic ulcers. Ann Vasc Surg. 2010, 24 (5): 690.e1-4. 10.1016\/j.avsg.2010.03.011.","journal-title":"Ann Vasc Surg"},{"key":"422_CR19","volume-title":"BMJ Case Reports","author":"J De Haro","year":"2009","unstructured":"De Haro J, Florez A, Fernandez JL, Acin F: Treatment of Buerger disease (thromboangiitis obliterans) with bosentan: a case report. BMJ Case Reports. 2009, doi:10.1136\/bcr.08.2008.0691. Published online: May 12th 2009. [ http:\/\/casereports.bmj.com\/content\/2009\/bcr.08.2008.0691 ]"},{"key":"422_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0140-6736(90)90346-7","volume":"335","author":"JN Fiessinger","year":"1990","unstructured":"Fiessinger JN, Sch\u00e4fer M: Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet. 1990, 335: 555-557. 10.1016\/0140-6736(90)90346-7.","journal-title":"Lancet"},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1078-5884(98)80032-4","volume":"15","author":"The European TAO Study Group","year":"1998","unstructured":"The European TAO Study Group: Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): A double-blind, randomized, placebo-controlled trial. Eur J Vasc Endovasc Surg. 1998, 15: 300-307.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"422_CR22","first-page":"255","volume":"168","author":"A Szuba","year":"1998","unstructured":"Szuba A, Cooke JR: Thromboangiitis Obliterans. An Update on Buerger's Disease. West J Med. 1998, 168: 255-260.","journal-title":"West J Med"},{"issue":"9 Suppl 2","key":"422_CR23","first-page":"211","volume":"94","author":"S Makita","year":"1996","unstructured":"Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K: Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation. 1996, 94 (9 Suppl 2): 211-215.","journal-title":"Circulation"},{"key":"422_CR24","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/art.22634","volume":"56","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M: Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum. 2007, 56: 1985-1993. 10.1002\/art.22634.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"422_CR25","first-page":"1346","volume":"61","author":"M Czarnacki","year":"2004","unstructured":"Czarnacki M, Gacka M, Adamiec R: A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news). Przegl Lek. 2004, 61 (12): 1346-50.","journal-title":"Przegl Lek"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-12-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T05:01:44Z","timestamp":1640754104000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-12-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-12-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]},"article-number":"5"}}